drugset / Trial / NCT03780595

Passiflora Extract for Benzodiazepine Withdrawal

NCT03780595

Phase 4 Unknown 108 enrolled Nutricion Medica S.L.
RandomizedParallel-groupTriple-blindTreatment

Summary

The aim of this clinical trials is compare the percentage of patient who achieve a reduction equal to or greater than 50% in the dose of benzodiazepines at 10 weeks of treatment.

Timeline

Start
2018-09-27
Primary completion
2019-06-30
Completion
2019-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Passiflora incarnata Unknown